Reyeton, the signs and signals and language from the Company point towards your and Nidan's thoughts being correct.
And as long as the looming binary moment is indeed ultimately positive, as logic/signs/signals/language would appear to indicate, then can't it be reasonably projected that Anavex is accomplishing what no other pharma has been able to accomplish after decades and tens of billions of research?
Maintaining AND improving above baseline for CNS disease sufferers (multiple indications through restoring cellular homeostasis)?
Isn't this what Dr M has been indicating and describing for a couple years at various presentations and interviews? He's holding these data cards very close to the vest for a reason. [It's now widely accepted that he couldn't hold poor/disappointing/ambiguous cards for this long without informing investors.]
Are all of these converging signs and signals and studies and abstracts and p/r languages all being put forth and published to cause the investment/scientific communities to come to the wrong conclusions?
I find it UNFATHOMABLE that the CEO/BOD/SAB/LEGAL TEAM would do that.
AIMHO of course.
News 
Market Data 
Discover 
